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Editorial
Immunohistochemistry (IHC) is the group of techniques that use 
antibodies as specific reagents to identify and demonstrate several 
cell and tissue components that are antigens. This linking allows 
locating and identifying the in situ presence of various substances 
by means of color that is associated with the formed antigen-
antibody complexes.
The practical value of this biotechnology area , widely used in 
Pathology and Oncology, in diagnostic, prognostic, theranostic 
and research context, results from the possibility of combining a 
colour marker with an antibody without causing any damage to 
specific binding established between antibody and antigen. This 
provides the microscopic observation of the target locations where 
the antibody and hence the antigen are present [1].
IHC is presented as a powerful means for identification of several 
cellular and tissue structures that can be associated with pathologies, 
and of the consequences, at functional and morphological level, of 
these same elements action.
In the last twenty years, there has been a progressive development 
of IHC, leading to an improvement in these methodologies for 
antigen demonstration in formaldehyde fixed, paraffin embedded 
tissues, which has contributed significantly for the diagnosis, 
prognosis and therapeutic guidance of several pathologies [2,3].
Nevertheless, some difficulties associated with the particularities of 
certain pathologies and technical limitations remain. Furthermore, 
the standardization of IHC has been a hard task to complete. The 
quality of the immunostaining depends on four main technical 
aspects [4].
i. Plan the full process in advance;
ii. Pre-analytical factors (emphasis on tissue fixation and proces-
sing);
iii. Antigen retrieval (AR)
iv. Sensitivity of the detection system.
Therefore, when using IHC techniques in research or clinical context, 
these technical aspects must be considered and addressed.
Plan the Full Process in Advance
The planning phase must entail the evaluation of all human, 
physical and material resources. The right procedures for all test 
stages, from sample collection to the final report as well as the 
use of registration, monitoring and traceability methods must be 
in place. All associated personnel (e.g. surgeons, nurses, general 
operations workers, oncologists, pathologists and biomedical 
scientists/technologists) must be trained and competent [5]. 
A full validation process must be performed for each test result 
and quality assurance procedures must be in place throughout all 
technical aspects e.g. quality control of reagents namely fixative 
solutions, dehydrating and impregnation agents and IHC reagents. 
Finally, all procedures must be reviewed and updated regularly in 
order to keep up with the most recent advances in the field.
Pre-analytical phase
The pre-analytical phase starts with the sample collection from the 
patient. Date and time of sample collection should be registered(start 
of cold ischemia time). All tissues must be immersed on an aqueous 
solution of 4% formaldehyde (10% formalin) phosphate buffered at 
pH 7.0 with a minimal volume of 4 times the dimensions of the 
tissue[6–10]. The cold ischemia time should be minimized and 
may extend to a maximum of 60 minutes [10–14]. Larger surgical 
specimens should be readily sliced and then immersed in fixative 
solution, for at least 24 hours with a temperature of 22 °C - 26 °C 
and should not exceed 96 hour of fixation time [6,7,10,12,15–17]. 
When grossing the specimens is not immediately possible, samples 
should be chilled to 4 °C, for no longer than 4 hours [10,12,15]. 
Samples transportation to the pathology laboratory must be done as 
soon as possible, under controlled conditions, respecting all safety 
standards for biological samples [6–10]. The surgical specimens 
that arrive at the laboratory not sliced and fixed, should be properly 
and immediately sliced and emerged in fixative solution according 
to the conditions set out above. The tissue processing should be 
automated and the reagents quality must be monitored taking into 
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consideration the amount and type of samples that go through 
them [10,17]. When biological tissues must remain in the tissue 
processor for more than 24 hours (public holidays or weekends) 
a delayed start with samples in fixative (first processing station) 
should be performed [10,17.] The embedding of samples must be 
done swiftly and the paraffin blocks must be stored at  20 °C - 25 
°C [7,10]. The microtomy conditions should always be kept similar 
for all samples. Section thickness should be 2-4μm and extension 
must be performed in water with controlled conductivity (e.g. 
distilled water). The water bath temperature must be constantly 
monitored at 50 °C maximum. Adhesion time and temperature 
must be constant, being advisable a temperature not exceeding 65 
°C [10,18]. Sections for IHC, ideally, should be cut and stained as 
soon as possible – it is known that histological sections with more 
than 6 weeks can lead to antigenicity change[6,7,9,10,18–21]. 
Antigen Retrieval
For the vast majority of antigens, formalin fixation will lead to a 
reduction of their functional affinity for the antibody (avidity) or 
even completely obliterate this affinity. A measurable effect that 
formalin fixation has on most tissue antigens is either reduced 
or absent immunostaining. AR, is the term used to describe 
the restoration of the antigen’s optimal immune reactivity after 
formalin fixation and, frequently, consists in high temperature 
heating of histological sections [22,23]. In 1945, Fraenkel-Conrat 
and colleagues [24] conducted several biochemical studies on the 
interactions between formaldehyde and proteins, demonstrating 
that the established cross links could be destroyed by heating to 
high temperatures or using strong alkaline solutions. Much later, in 
1991, Shi and colleagues discovered that submitting IHC slides to 
high temperature when immersed in specific solutions was a very 
important and effective step. These researchers demonstrated the 
great benefits of this treatment on many antigens immunostaining, 
which was particularly intriguing taking into account the presumed 
deleterious effects of high temperatures on protein antigens [25].
Although it is known that proteins denature between 70 °C and 
90 °C, it appears that fixed tissues resist denaturing at these 
temperatures [26]. Many other researchers were able to demonstrate 
this phenomenon, in particular Kawai et al. They concluded that 
90 °C  for 10 minutes AR is more effective than 60 °C for 120 
minutes  [27]. In 1993, Cattoretti and collaborators, confirmed the 
effectiveness of this procedure and suggested alternatives to the 
heavy metals AR solution used previously [28]. Since then, the pH 
6.0 0.01M citrate buffer became one of the most widely used AR 
solutions. However, later it was found there is not one AR solution 
that fits universally all types of antigen. Thus, several antibodies 
should be tested until the AR optimal conditions are found. Other 
very important factor is the solutions pH [29]. Some researchers 
have even found the pH value of an AR solution is more important 
than their chemical composition, particularly for nuclear and cell 
membrane antigens [29]. The presence of chelating agents, that 
promote the extraction of calcium ions affect AR and some antigens 
are more prone to react with certain chelating agents, usually 
ethylenediamine tetraacetic acid (EDTA), amongst others [30,31].
Several high temperature methods were tested such as microwave 
oven [25], autoclave [32–35], pressure cooker [36,37], water bath 
[27] and hot steam [38,39].
The AR success demonstrated that the modified protein structure 
induced by formaldehyde is a reversible process and that the 
proteins retain their primary structure.
The introduction of AR methods was undoubtedly one of the 
major advances in IHC – before its implementation only a small 
percentage of antigens could effectively be detected.
Sensitivity of the detection system
Antibodies are proteins and, therefore, they are not naturally 
stained. So, it is necessary to make them microscopically visible 
when they are linked to the antigen. In 1941, Albert Coons and 
his collaborators conjugated a fluorescent marker to the antibody 
and this allowed the identification of the antigen [40]. However, at 
the time, the ratio of marker per tissue antigen was very low, and 
amplification was poor in most cases. The false negative rate was, 
then, high, and this narrowed the viability of IHC to exceptional 
and sporadic situations.
The ultimate goal has been, ever since, to create a stable staining 
method with enough intensity to eliminate doubt about the 
presence or absence of the antigen in the tissue [1]. Over the years 
abundant ways to increase the signal that is associated with tissue 
antigen have been developed–e.g. Simple indirect method, PAP 
method, avidin-biotin methods [41–46]. Some of these methods 
were never widely used, some others were often used back then and 
barely used currently [47].
Today there is a simple method that offers a higher amplification: 
the indirect polymer method [48,49]. The use of polymers in IHC 
brought 4 major advantages: higher amplification rate, lower error 
rate, faster turnaround time and simplicity of the method [50,51]. 
These systems do not have (strept)avidin or biotin and therefore the 
use of blocking reagents is unnecessary. The major disadvantage 
is its higher cost which, can be seen as a "minor" factor given its 
benefits [52].
Currently, there are several IHC methods that use polymers with 
a high signal amplification, namely the internal skeleton polymer 
and the enzymes micropolymer.
The internal skeleton polymer relies on a macromolecule consisting 
of a large central skeleton to which are attached large amounts of 
antibody molecules and enzymes, like horseradish peroxidase(HRP) 
[49]. The central skeleton molecule is dextran, a high molecular 
weight polysaccharide that can reach 500 kDa. Dextrans consist 
of a sequences of α-D-glucose units predominately linked by α-1,6 
glycosidic bonds. They are manufactured from sucrose during 
growth of bacteria belonging to the Leuconostoc, Streptococcus 
and Lactobacillusgenera, all belonging to the Lactobacillaceafamily. 
However, most of the dextrans are synthesized by the bacterium 
Leuconostoc mesenteroides species. The dextran has a neutral pH, 
it is soluble in water and it is highly stable.
The enzymes micropolymers methods are based on the enzyme 
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polymerization and its association to antibodies, forming enzyme 
micropolymers. According to its manufacturers this approach 
avoids the problems arising from the use of an internal skeleton. The 
micropolymer, with a high density of very active enzyme, coupled 
to a secondary antibody generates a reagent which overcomes the 
steric interference that emerge from the huge dimensions occupied 
by the internal skeleton polymer. This method provides greater 
accessibility to the antigen and, due to the micropolymer’s small 
size, it increases reagents diffusion to the target and reduces non-
specific binding.
Conclusion
Oncology research and clinical decisions are largely based on 
IHC results. Considering all the multifactorial aspects that can 
bring bias to these results, it is essential that the IHC Laboratory 
procedural proficiency is established. Basic standardization and 
reproducibility of all methodologies, including internal and 
external quality control measures must be regularly applied to 
provide slides of diagnostic quality. The participation in IHC 
external quality assessments using consensual schemes such as 
UKNEQAS (http://www.ukneqasiccish.org/) and others, is of utter 
importance to measure effectiveness.
References
1.  Polak JM, Van Noorden � (2003) Introduction to Immunocytochemistry. 
Oxford: BIOS Scientific Publishers.
2. �wanson P� (2015) Immunohistochemistry as a surrogate for molecu-
lar testing: a review. 23(2): 81-96. 
3. Werner M (1999) Tissue fixation and antigen retrieval. Rev Esp Patol 
32(3): 355-361.
4. Ramos-Vara JA (2005) Technical Aspects of Immunohistochemistry. 
Vet Pathol Online 42(4): 405-426. 
5. Arafah M, Kfoury HK, Zaidi �N (2010) H�R2/neu Immunostaining in 
Invasive Breast Cancer: Analysis of False Positive Factors. Oman Med 
J 25(4): 261-263. 
6. Wolff AC, Hammond MEH, Hicks DG, Dowsett M, McShane LM, et 
al. (2013) Recommendations for Human Epidermal Growth Factor 
Receptor 2 Testing in Breast Cancer: American Society of Clinical 
Oncology/College of American Pathologists Clinical Practice Guideline 
Update. J Clin Oncol 31(31): 3997-4013. 
7. Albanell J, Andreu X, Calasanz MJ, Concha A, Corominas JM, et al. 
(2009) Guidelines for HER2 testing in breast cancer: a national 
consensus of the �panish �ociety of Pathology (��AP) and the �panish 
Society of Medical Oncology (SEOM). Clin Transl Oncol Off Publ Fed 
�pan Oncol �oc Natl Cancer Inst Mex 11(6): 363-375.
8. Goldstein NS, Hewitt SM, Taylor CR, Yaziji H, Hicks DG, et al. 
(2007) Recommendations for improved standardization of 
immunohistochemistry. Appl Immunohistochem Mol Morphol AIMM 
Off Publ Soc Appl Immunohistochem 15(2): 124-133. 
9. Gomez-Martin C, Concha A, Corominas JM, Garcia-Caballero T, Garcia-
Garcia E, et al. (2011) Consensus of the �panish �ociety of Medical 
Oncology (��OM) and �panish �ociety of Pathology (��AP) for H�R2 
testing in gastric carcinoma. Clin Transl Oncol Off Publ Fed Span Oncol 
�oc Natl Cancer Inst Mex 13(9): 636-651.
10. Maia-Matos M, Ferro A, Teixeira A, Cristina Gavinho, Ana Cunha, et 
al. Consenso Tecnico para a determinacao do status da proteina H�R2 
por imunocitoquímica em carcinoma da mama. �aude Tecnol (#T1): 
71-82.
11. Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, et 
al.(2010) American �ociety of Clinical Oncology/College of American 
Pathologists guideline recommendations for immunohistochemical 
testing of estrogen and progesterone receptors in breast cancer 
(unabridged version). Arch Pathol �ab Med 134(7): e48-e72. 
12. Yildiz-Aktas IZ, Dabbs DJ, Bhargava R (2012) The effect of cold 
ischemic time on the immunohistochemical evaluation of estrogen 
receptor, progesterone receptor, and H�R2 expression in invasive 
breast carcinoma. Mod Pathol Off J U S Can Acad Pathol Inc 25(8): 
1098-1105. 
13. Khoury T (2012) Delay to formalin fixation alters morphology and 
immunohistochemistry for breast carcinoma. Appl Immunohistochem 
Mol Morphol AIMM Off Publ Soc Appl Immunohistochem 20(6): 531-
542. 
14. Moatamed NA, Nanjangud G, Pucci R, Lowe A, Shintaku IP, et al.(2011) 
Effect of ischemic time, fixation time, and fixative type on HER2/neu 
immunohistochemical and fluorescence in situ hybridization results 
in breast cancer. Am J Clin Pathol 136(5): 754-761.
15. Perry N, Broeders M, de Wolf C, Tornberg �, Holland R, et al. (2008) 
�uropean guidelines for quality assurance in breast cancer screening 
and diagnosis. Fourth edition--summary document. Ann Oncol Off J 
�ur �oc Med Oncol ��MO19(4): 614-622.
16. Tong LC, Nelson N, Tsourigiannis J, Mulligan AM (2011) The effect 
of prolonged fixation on the immunohistochemical evaluation of 
estrogen receptor, progesterone receptor, and H�R2 expression in 
invasive breast cancer: a prospective study. Am J Surg Pathol 35(4): 
545-552. 
17. Yildiz-Aktas IZ, Dabbs DJ, Cooper KL, Chivukula M, McManus K, et 
al.(2012) The effect of 96-hour formalin fixation on the immunohis-
tochemical evaluation of estrogen receptor, progesterone receptor, 
and H�R2 expression in invasive breast carcinoma. Am J Clin Pathol 
s137(5): 691-698. 
18.  Thurby C, White MR, Simutis F, Gillham S, Slinker D, et al. (2009) 
An Improved Method of Tissue Adhesion on Glass Microslides for 
Immunohistochemical Evaluation by the Use of Selected Tissues from 
the Dog and Monkey. J Histotechnol 32(4): 198-201. 
19. Henson D� (1996) �oss of p53-immunostaining intensity in breast 
cancer. J Natl Cancer Inst 88(15): 1015-1016.
20. Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ (1996) Loss of tumor 
marker-immunostaining intensity on stored paraffin slides of breast 
cancer. J Natl Cancer Inst 88(15): 1054-1059.
21. Manne U, Myers RB, Srivastava S, Grizzle WE (1997) Re: loss of tumor 
marker-immunostaining intensity on stored paraffin slides of breast 
cancer. J Natl Cancer Inst 89(8): 585-586.
22. Boenisch T (2006) Heat-induced Antigen Retrieval: What Are We 
Retrieving? J Histochem Cytochem. 2006;54(9): 961-964. 
23. Shi S-R, Cote RJ, Taylor CR (2001) Antigen Retrieval Techniques Current 
Perspectives. J Histochem Cytochem 49(8): 931-937. 
24. Fraenkel-Conrat H, Cooper M, Olcott HS (1945) The Reaction of 
Formaldehyde with Proteins. J Am Chem �oc 67(6): 950-954.
Page 4 of 4Citation: Amadeu Borges-Ferro (2016) Oncology Research and Clinical Decisions Based on Immunohistochemistry: The Importance of 
the Technical Aspects That �upport a Complex Method. BAOJ Cancer Res Ther 2: 022.
BAOJ Cancer Res Ther, an open access journal                                                           Volume 2; Issue 5; 022
25. Shi SR, Key ME, Kalra KL (1991) Antigen retrieval in formalin-
fixed, paraffin-embedded tissues: an enhancement method for 
immunohistochemical staining based on microwave oven heating 
of tissue sections. J Histochem Cytochem Off J Histochem Soc 39(6): 
741-748.
26. Leong ASY, Milios J, Leong FJWM (1996) Epitope retrieval with 
microwaves. A comparison of citrate buffer and EDTA with three 
commercial retrieval solutions. Appl Immunohistochem (4): 201-207.
27. Kawai K, Serizawa A, Hamana T, Tsutsumi Y (1994) Heat-induced 
antigen retrieval of proliferating cell nuclear antigen and p53 protein 
in formalin-fixed, paraffin-embedded sections. Pathol Int 44(10-11): 
759-764. 
28. Cattoretti G, Pileri S, Parravicini C, Becker MH, Poggi �, et al. (1993) 
Antigen unmasking on formalin-fixed, paraffin-embedded tissue 
sections. J Pathol 171(2): 83-98.
29. Shi SR, Imam SA, Young L, Cote RJ, Taylor CR, et al. (1995) Antigen 
retrieval immunohistochemistry under the influence of pH using 
monoclonal antibodies. J Histochem Cytochem Off J Histochem Soc 
43(2): 193-201.
30. Morgan JM, Navabi H, �chmid KW, Jasani B (1994) Possible role of 
tissue-bound calcium ions in citrate-mediated high-temperature 
antigen retrieval. J Pathol 174(4): 301-307. 
31. Morgan JM, Navabi H, Jasani B (1997) Role of Calcium chelation in 
high-temperature antigen retrieval at different pH values. J Pathol 
182(2): 233-237.
32. Bankfalvi A, Navabi H, Bier B, Bocker W, Jasani B, et al.(1994) 
Wet autoclave pretreatment for antigen retrieval in diagnostic 
immunohistochemistry. J Pathol.174(3): 223-228. 
33. Igarashi H, Sugimura H, Maruyama K, Kitayama Y, Ohta I, et al. (1994) 
Alteration of immunoreactivity by hydrated autoclaving, microwave 
treatment, and simple heating of paraffin-embedded tissue sections. 
APMI� 102(1-6): 295-307. 
34. Umemura S, Kawai K, Osamura RY, Tsutsumi Y (1995) Antigen retrieval 
for bcl-2 protein in formalin-fixed, paraffin-embedded sections. 
Pathol Int 45(2): 103-107. 
35. Pons C, Costa I, Von Schilling B, Matias-Guiu B, Prat J, et al. (1995) 
Antigen Retrieval by Wet Autoclaving for p53 Immunostaining. Appl 
Immunohistochem 3(4): 265-267.
36. Norton AJ, Jordan S, Yeomans P (1994) Brief, high-temperature heat de-
naturation (pressure cooking): a simple and effective method of anti-
gen retrieval for routinely processed tissues. J Pathol 173(4): 371-379. 
37. Miller RT, �stran C (1995) Heat-induced epitope retrieval with a 
pressure cooker - suggestions for optimal use. Appl Immunohistochem 
3: 190-193.
38. Pasha T, Montone K, Tomaszewski J (1995) Nuclear antigen retrieval 
utilizing steam heat. 72: 167A.
39. Taylor CR, Chen C, Shi SR, Yang C, Cote RJ, et al.  (1995) A comparative 
study of antigen retrieval heating methods. CAP Today 9:16-22.
40. Coons AH, Creech HJ, Jones RN (1941) Immunological Properties of an 
Antibody Containing a Fluorescent Group. Exp Biol Med 47(2): 200-202. 
41. Sternberger LA, Hardy PH, Cuculis JJ, Meyer HG (1970) The Unlabeled 
Antibody Enzyme Method of Immunohistochemistry Preparation 
and Properties of Soluble Antigen-Antibody Complex (horseradish 
Peroxidase-Antihorseradish Peroxidase) and Its Use in Identification 
of �pirochetes. J Histochem Cytochem 18(5): 315-333.
42. Scopsi L, Larsson LI (1986) Increased sensitivity in peroxidase 
immunocytochemistry. A comparative study of a number of peroxidase 
visualization methods employing a model system. Histochemistry 
84(3): 221-230.
43. Guesdon JL, Ternynck T, Avrameas S, J C Hierholzer (1979) The use 
of avidin-biotin interaction in immunoenzymatic techniques. J 
Histochem Cytochem Off J Histochem Soc 27(8): 1131-1139.
44. von Wasielewski R, Mengel M, Gignac S, Wilkens L, Werner M, et 
al. (1997) Tyramine amplification technique in routine immuno-
histochemistry. J Histochem Cytochem Off J Histochem Soc 45(11): 
1455-1459.
45. Vyberg M, Nielsen � (1998) Dextran polymer conjugate two-step 
visualization system for immunohistochemistry. A comparison 
of EnVision+ with two three-step avidin-biotin techniques. Appl 
Immunohistochem 6(1): 3-10.
46. Heras A, Roach C, Key M (1995) Enhanced polymer detection system 
for immunohistochemistry. 
47. Vosse BAH, Seelentag W, Bachmann A, Bosman FT, Yan P, et al. (2007) 
Background staining of visualization systems in immunohistochemistry: 
comparison of the Avidin-Biotin Complex system and the EnVision+ 
system. Appl Immunohistochem Mol Morphol 15(1): 103-107.
48. Wong �CC, Chan JKC, �o ��F, Amanda KC, Manson CK et al. (2007) 
The contribution of bifunctional SkipDewax pretreatment solution, 
rabbit monoclonal antibodies, and polymer detection systems in 
immunohistochemistry. Arch Pathol �ab Med 131(7): 1047-1055. 
49. Sabattini E, Bisgaard K, Ascani S, S Poggi, M Piccioli, et al. (1998)The 
�nVision++ system: a new immunohistochemical method for diag-
nostics and research. Critical comparison with the APAAP, Chem-
Mate, C�A, �ABC, and �ABC techniques. J Clin Pathol 51(7): 506-511.
50. Petrosyan K, Tamayo R, Joseph D (2002) Sensitivity of a novel Biotin-
free detection reagent (PowerVision+) for immunohistochemistry. J 
Histotechnol 25: 247-250.
51. Kammerer U, Kapp M, Gassel AM, Richter T, Tank C, et al. (2001) 
A new rapid immunohistochemical staining technique using the 
EnVision antibody complex. J Histochem Cytochem Off J Histochem 
�oc 49(5): 623-630.
52. Wiedorn KH, Goldmann T, Henne C, Kuhl H, Vollmer E, et al. (2001) 
�nVision, a new dextran polymer-based signal enhancement 
technique for in situ hybridization (ISH). J Histochem Cytochem Off J 
Histochem �oc 49(9): 1067-1071.
